Pediatric Neurology
Volume 20, Issue 3 , Pages 192-194, March 1999

Subclinical hyperthyroidism and hyperkinetic behavior in children

  • Poovathinal A Suresh, MD, DM

      Affiliations

    • Section of Speech and Behavioural Neurology; Department of Neurology; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum, Kerala, India
    • Corresponding Author InformationCommunications should be addressed to: Dr. Suresh; Department of Neurology; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum, 695 011, India
  • ,
  • Swapna Sebastian, MSc

      Affiliations

    • Section of Speech and Behavioural Neurology; Department of Neurology; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum, Kerala, India
  • ,
  • Annamma George, MSc

      Affiliations

    • Section of Speech and Behavioural Neurology; Department of Neurology; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum, Kerala, India
  • ,
  • Kurupath Radhakrishnan, MD, DM

      Affiliations

    • Section of Speech and Behavioural Neurology; Department of Neurology; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Trivandrum, Kerala, India

Received 17 April 1998; accepted 15 October 1998.

Abstract 

The authors report three children who exhibited developmental learning disabilities (DLDs) associated with behavioral disturbances, such as attention deficit, hyperactivity, and autistic features. The thyroid function tests performed as a part of routine endocrinologic evaluation of children with DLDs revealed a hormonal profile consistent with hyperthyroidism. These children had no systemic signs of hyperthyroidism. Treatment with neomercazole resulted in good control of their hyperkinetic behavior and subsequent improvement in language function attributable to an increased attention span, thereby facilitating speech therapy. Although routine screening of all children with DLDs for thyroid dysfunction may not be cost-effective, selective screening of children with familial attention-deficit hyperactivity disorder and those with attention-deficit and hyperactivity in association with DLDs and pervasive developmental disorders appears to be justified.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(98)00133-7

Pediatric Neurology
Volume 20, Issue 3 , Pages 192-194, March 1999